Olga Tselousova
Mechnikov North-Western State Medical University , Russian FederationTitle: A genetic approach to secondary breast cancer prevention
Abstract
Breast cancer, the most
diagnosed cancer in women, results from combined effects of genetic and
environmental factors. Modification of DNA repair system activity and cell
inability to restore damaged DNA determine the initiation of carcinogenesis.
Mutated genes of the BRCA family lead
to the formation of dysfunctional DNA repair proteins that are unable to
perform the function. Non-repaired DNA initiates genetic instability with an
increased risk of the oncogenic transformation of non-tumorigenic cells into
malignant initiating cells. This suggests that personalized prevention
strategies should be considered based on individual genetic profiles. An
increasing amount of research indicates that genetic factors can influence the
relationship between diet, exercise, obesity, and environmental factors and the
risk of breast cancer. The genetic approach to secondary breast cancer
prevention involves understanding how genetic factors, such as mutations in
genes like BRCA, interact with
environmental factors to increase the risk of breast cancer. By identifying
individuals with specific genetic profiles that predispose them to a higher
risk of developing breast cancer, targeted preventive strategies can be
implemented. We have shown a high frequency of mutant alleles and 6-fold higher
risk of mutation formation of the BRCA
genes in residents of the observation zone where petrochemical production
enterprises are concentrated. Studying gene–environment interaction offers the
opportunity to obtain new knowledge on several aspects of breast cancer
etiology and it may help to improve preventive strategies for personalized
health care. These include behavior modification for high-risk subjects
(primary prevention), early detection and extensive monitoring of genetically
susceptible subjects and noninvasive treatment of early stage cancer cases
(secondary prevention), and finally prophylactic and therapeutic intervention
to slow diseases progression (tertiary prevention).
Biography
Olga
Tselousova, associate professor, clinical scientist, geneticist with more than
14 years of life sciences and healthcare experience. She has developed an
innovative educational program in the field of nuclear medicine and management
of the diagnostic and therapeutic process, awarded the prize for the best
practice in the field of medical and pharmaceutical education in Russia.